Pelviprost somatic 20 tablets

SOMATIC

Description
Co-micronized palmitoylethanolamide/polydatin.
Contains a patented and body-usable form of palmitoylethanolamide (micronized and ultra-micronized, in combination with polyphenol and the flavonoid baicalein.

Ingredients
Micronized palmitoylethanolamide (particle size 2.0-10.0 microns), ultra-micronized palmitoylethanolamide (particle size 0.8 -0.6); bulking agent: microcrystalline cellulose; coating agents: polyvinyl alcohol, calcium carbonate, polyethylene glycol, talc, E132; micronized polydatin; skullcap (Scutellaria baicalensis Georgi) root extract; stabilizers: polyvinylpyrrolidone, cross-linked sodium carboxymethylcellulose; anti-caking agents: silicon dioxide, magnesium salts of fatty acids; emulsifier: polysorbate 80.

Nutritional characteristics

Average values	1 tablet	100 g
Energy	7.12 kcal/29.8 kJ	569 kcal/2.383 kJ
Proteins	<0.01g	<1.0g
Carbohydrates of which sugars	<0.01g <0.01g	<1.0g
Fats of which saturated fatty acids	0.79 g 0.68 g	63.0 g 54.2 g
Dietary fiber	0.23 g	20.0 g
Salt	0.01 g	0.6 g

Average values	1 tablet	2 tablets	100 g
Palmitoylethanolamide	0.800 g	1,600 g	64.0 g
Polydatin	0.040 g	0.080 g	3.20 g
Baicalein	0.040 g	0.080 g	3.20 g

How to use
It is recommended to take one tablet, preferably on a full stomach, 1-2 times a day.

Warnings
Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle. Do not take during pregnancy and breastfeeding. Keep out of reach of children under three years of age. Avoid use in cases of suspected or confirmed hypersensitivity to one of the ingredients. Do not exceed the recommended daily dose. The expiry date refers to the product correctly stored, in intact packaging.

Conservation
Store the product in a cool, dry place. Avoid exposure to localized heat sources, sunlight and contact with water.
Validity with intact packaging: 36 months.

Format
Pack of 20 tablets.
Net weight: 25 g.

Cod. 8029